Eurofins Genomics Blue Heron announced the launch of its IVT mRNA Synthesis Service.
The new service offers a comprehensive solution for researchers seeking high-quality, customizable mRNA synthesis with fast turnaround times. The IVT mRNA Synthesis Service is based on the latest in vitro transcription (IVT) technology, which allows for the rapid and efficient synthesis of high-quality messenger RNA (mRNA) transcripts.
The IVT mRNA Synthesis Service has been designed to meet the needs of scientists in a wide range of fields, including molecular biology, drug discovery, vaccine development, and gene therapy. With our service, researchers can customize mRNA transcripts to suit their specific research needs, including modifying the sequence, length, and purity of the mRNA.
IVT mRNA Synthesis Service offers:
- High-quality mRNA synthesis for a wide range of applications
- Fast turnaround times and delivery options
- Customizable mRNA synthesis to meet specific research needs
- Competitive pricing to fit all budgets
- A dedicated team of experts to assist with all aspects of the synthesis process
"We are excited to offer this groundbreaking service to the scientific community," said Isaiah Chuang, President of Eurofins Genomics Blue Heron. "Our IVT mRNA Synthesis Service is a game-changer for researchers seeking to advance their work in gene expression research, drug discovery, and beyond. We look forward to partnering with researchers to help them achieve their goals."
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!